Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN65,265,220,02
Msft-0,74
Nokia3,32053,3835-0,30
IBM-1,06
Mercedes-Benz Group AG63,5863,59-1,35
PFE0,88
20.07.2024 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 19.07.2024
Prestige Br Hldg (PBH, NY Consolidated)
Závěr k 19.7.2024 Změna (%) Změna (USD) Objem obchodů (ks)
71,24 -0,46 -0,33 214 139
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 22.07.2024
Popis společnosti
Obecné informace
Název společnostiPrestige Consumer Healthcare Inc
TickerPBH
Kmenové akcie:Ordinary Shares
RICPBH
ISIN-
Poslední známé roční výsledky31.03.2024
Poslední známé čtvrtletní výsledky31.03.2024
Počet zaměstnanců k 31.03.2024 570
Akcie v oběhu k 10.06.2024 49 675 033
MěnaUSD
Konstituent indexůS&P 600 Small Cap
Kontaktní informace
Ulice660 White Plains Rd
MěstoTARRYTOWN
PSČ10591-5139
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon19 145 246 800
Fax13026745266

Business Summary: Prestige Consumer Healthcare Inc. is consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. It operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
Financial Summary: BRIEF: For the fiscal year ended 31 March 2024, Prestige Consumer Healthcare Inc revenues remained flat at $1.13B. Net income totaled $209.3M vs. loss of $82.3M. Revenues reflect North American OTC Healthcare-Eye & Ear Care segment increase of 3% to $156.6M, North American OTC Healthcare-Gastrointestinal segment increase of 3% to $160.9M, International OTC Healthcare-Women's Health segment increase of 19% to $23.3M.
Odvětvová klasifikace
TRBC2012Pharmaceuticals (NEC)
RBSS2004Pharmaceuticals - Generic & Specialty
MGINDUSTRYRetail (Drugs)
MGSECTORServices
NAICSPharmacies and Drug Retailers
NAICS2007Pharmacies and Drug Stores
NAICS1997Pharmacies and Drug Stores
SICPharmaceutical Preparations
SICDrug Stores/proprietary Stores



  • Poslední aktualizace: 22.07.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, President, Chief Executive OfficerRonald Lombardi6011.05.201706.12.2010
Chief Financial OfficerChristine Sacco4912.09.201612.09.2016
Executive Vice President - Marketing & SalesAdel Mekhail6313.05.201913.05.2019
Senior Vice President, General Counsel, Corporate SecretaryWilliam P'Pool58
Senior Vice President - OperationsJeffrey Zerillo63